A Phase III Study to Evaluate the Port Delivery System With Ranibizumab Compared With Monthly Ranibizumab Injections in Participants With Wet Age-Related Macular Degeneration
Clinical trial NCT03677934 · COMPLETED
Trial details
- NCT number
- NCT03677934
- Sponsor
- Hoffmann-La Roche
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2018-09-12
- Primary completion
- 2020-05-22
- Enrollment
- 415
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.